Feb. 8, 2004 — Thiazolidinediones and metformin are not only not harmful, but may actually be helpful for older patients with diabetes and heart failure, according to the results of a retrospective, ...
MedPage Today on MSN
GLP-1 drugs may benefit cancer patients with brain lesions
Retrospective study finds link between blockbuster drugs and longer survival ...
Purpose: A review of the significant findings related to the use of the thiazolidinediones (TZDs) in the treatment of patients with type 2 diabetes mellitus and heart failure was conducted. Summary: ...
Combination therapy with GLP-1 RA and thiazolidinedione significantly reduces all-cause mortality and cardiovascular mortality in type 2 diabetes patients. The study found an increased risk of ...
Scientists at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have discovered a key biological reason why obesity increases the risk of type 2 diabetes, and it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results